Therefore, the correction procedure developed by Kurth and Ellert with data of KiGGS baseline (formula 16) [ 10] (i.e. the statistical procedure of directly correcting the prevalence rates) was replicated here in order to derive a new correction formula for KiGGS Wave 1.
However, few authors of such surveys take into account the sensitivity error associated with the use of a screening procedure in the first phase and its imprecision in correcting the prevalence estimate and confidence interval.
Similar to US reports [ 6], we corrected the prevalence for vitamin and mineral supplements and religious healing and still found a notable prevalence of 50.7%.
At the animal level, true prevalence (TP) was then calculated by correcting the apparent prevalence point estimates and confidence limits using the formula described by Rogan and Gladen [ 33]: TP = (AP + Sp – 1) / (Se + Sp – 1), where AP = apparent prevalence, Se = sensitivity, Sp = specificity.
We therefore corrected the birth prevalence in year 2005 using an adjustment procedure that is based on the age specific detection rates for congenital heart defects from the birth cohorts with a complete three year follow-up.
To compensate for this the matrices were corrected for the prevalence of amino acids residues at each position in the total data set.
cCost for the annual number of new patients undergoing a HER2 test and receiving systemic treatment in the USA IVD in vitro diagnostic aCosts corrected for the prevalence of IHC 2+ tumours [ 19]. bProductivity loss per year per patient undergoing a HER2 test.
Therefore, use of approved rather than laboratory-developed IVD tests could result in a saving of approximately $46 million.> -wrap-foot>> -wrap-foot> IVD in vitro diagnostic aCosts corrected for the prevalence of IHC 2+ tumours [ 19]. bProductivity loss per year per patient undergoing a HER2 test.
*for region beyond Esmeraldo 5' deletion; translation includes correction of frameshift in Sylvio **through available Sylvio sequence, ~1600 of ~1770 nts; Esmeraldo translation corrected for frameshifts The prevalence of SNPs varied between 10.8% and 14% among this subset of genes.
The corrected prevalence was calculated by multiplying the crude rate from the MDC or ISC by the positive predictive values (PPV) from the validation studies and dividing by the sensitivity[ 22, 23].
